SEC 13F Intelligence

Venrock Adviser, LLC / DYN

Venrock Adviser, LLC’s Dyne Therapeutics Inc Position

Does Venrock Adviser, LLC own Dyne Therapeutics Inc (DYN)? Yes — 2.17M shares worth $39M (+1.47% of its 13F portfolio) as of Q1 2026.

Position Value
$39M
Q1 2026
Shares
2.17M
% of Portfolio
+1.47%
Quarters Held
12
currently held

Position History DYN

Reported value by quarter
Q2 ’23: $24MQ2 ’23Q3 ’23: $19MQ4 ’23: $29MQ4 ’23Q1 ’24: $62MQ2 ’24: $77MQ2 ’24Q3 ’24: $78MQ4 ’24: $51MQ4 ’24Q1 ’25: $23MQ2 ’25: $21MQ2 ’25Q3 ’25: $27MQ4 ’25: $43MQ4 ’25Q1 ’26: $39Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.17M$39M+1.47%
Q4 20252.17M$43M+2.10%
Q3 20252.17M$27M+1.55%
Q2 20252.17M$21M+1.55%
Q1 20252.17M$23M+1.93%
Q4 20242.17M$51M+3.51%
Q3 20242.17M$78M+4.09%
Q2 20242.17M$77M+4.89%
Q1 20242.17M$62M+2.94%
Q4 20232.17M$29M+1.98%
Q3 20232.17M$19M+2.05%
Q2 20232.17M$24M+3.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Venrock Adviser, LLC’s full portfolio or all institutional holders of DYN.